News
Queen Mary spin-out company in Britain's top 20 fastest growing private technology companies
3 October 2007
Developed from the Interdisciplinary Research Centre in Biomedical Materials at QMUL's Department of Materials, ApaTech is an excellent example of how innovative technology from a UK university can be developed and commercialised on a global scale.
The spin-out company has been ranked as Britain's 13th fastest growing private technology company in the ‘Tech Track 100’ league table produced by The Sunday Times .
Established in 2001, ApaTech is now a world leader in bone graft technologies and its products are used in 18 countries. The company manufactures and markets synthetic bone substitutes, ApaPore and Actifuse, which have received regulatory approval for surgical use in the UK, Europe, Australasia and the USA.
To date, ApaTech has raised £12.2 million of equity from venture capitalists 3i plc and leading UK technology investor MTI, plus £3.5 million of debt from Noble Ventures. ApaTech Limited currently has 45 employees, with 11 staff employed by the US subsidiary, ApaTech Inc., and a further four in the newly established ApaTech GmbH. Multiple clinical studies are under way in centres of excellence around the world, providing evidence of the superiority of ApaTech’s products. ApaTech is on the verge of operating profitability and cash flow breakeven, and is currently raising funds for significant expansion.
ApaTech was recently shortlisted for the ‘Business Initiative of the Year’ category in the Times Higher Education Awards 2007. The winners will be announced at an Awards dinner on 29 November.
The spin-out company has been ranked as Britain's 13th fastest growing private technology company in the ‘Tech Track 100’ league table produced by The Sunday Times .
Established in 2001, ApaTech is now a world leader in bone graft technologies and its products are used in 18 countries. The company manufactures and markets synthetic bone substitutes, ApaPore and Actifuse, which have received regulatory approval for surgical use in the UK, Europe, Australasia and the USA.
To date, ApaTech has raised £12.2 million of equity from venture capitalists 3i plc and leading UK technology investor MTI, plus £3.5 million of debt from Noble Ventures. ApaTech Limited currently has 45 employees, with 11 staff employed by the US subsidiary, ApaTech Inc., and a further four in the newly established ApaTech GmbH. Multiple clinical studies are under way in centres of excellence around the world, providing evidence of the superiority of ApaTech’s products. ApaTech is on the verge of operating profitability and cash flow breakeven, and is currently raising funds for significant expansion.
ApaTech was recently shortlisted for the ‘Business Initiative of the Year’ category in the Times Higher Education Awards 2007. The winners will be announced at an Awards dinner on 29 November.